Table 2.
Sensitivity and specificity compared to manufacturers' data from samples collected ≥14 days (Abbott, Roche) and >15 days (DiaSorin) post PCR confirmation.
| Study data |
Manufacturers' dataa |
|||||||
|---|---|---|---|---|---|---|---|---|
| n | Sensitivity % (95% CI) | n | Specificity % (95% CI) | n | Sensitivity % (95% CI) | n | Specificity % (95% CI) | |
| Abbott | 152 | 80.9 (74.0–86.4) | 150 | 99.3 (96.3–100) | 88 | 100 (95.9–100) | 997 | 99.6 (99.0–99.9) |
| Roche | 152 | 98.7 (95.3–99.8) | 150 | 98.7 (95.3.99.8) | 185 | 99.5 (97.0–100) | 6305 | 99.8 (99.7–99.9) |
| DiaSorin | 145 | 89.0 (82.8–93.1) | 148 | 97.3 (93.3–98.9) | 48 | 97.9 (89.1–99.6) | 1200 | 98.6 (97.7–99.1) |
| Dynamiker | 152 | 72.4 (64.8–78.9) | 150 | 96.7 (92.4–98.6) | 162 | 93.2 (not reported) | 300 | 95.3 (not reported) |
No information about the time of sampling was available for Dynamiker Biotechnology.
a
Data retrieved from following versions of product kit inserts: Abbott 6R86 H0791R04, June 2020; Roche V3, 2020-06; DiaSorin 200/007-797, 07, 2020-07; Dynamiker Biotechnology DNK-1419-1.